BetterLife Pharma (BETRF) Market Capitalization (2011 - 2026)

BetterLife Pharma has reported Market Capitalization for 16 years, with the latest figure at $7.6 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 13.0% year-over-year to $7.6 million in Q2 2026; TTM through Apr 2026 was $7.6 million, a 13.0% decrease from a year earlier, with the FY2026 full-year figure at $6.1 million, down 53.6% from the prior year.
• Market Capitalization was $7.6 million for Q2 2026 at BetterLife Pharma, up from $6.1 million in the prior quarter.
• The five-year high for Market Capitalization was $13.6 million in Q1 2022, with the low at $4.3 million in Q3 2023.
• Average Market Capitalization over 5 years is $8.8 million, with a median of $9.4 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization sank 57.69% in 2023, then soared 197.57% in 2024.
• Over 5 years, Market Capitalization stood at $10.2 million in 2022, then tumbled by 57.69% to $4.3 million in 2023, then jumped by 89.36% to $8.2 million in 2024, then grew by 24.27% to $10.2 million in 2025, then fell by 25.43% to $7.6 million in 2026.
• The last three Market Capitalization figures came in at $7.6 million (Q2 2026), $6.1 million (Q1 2026), and $10.2 million (Q3 2025), per Business Quant data.